cirrhotic


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to cirrhotic: Hepatic cirrhosis

cir·rhot·ic

(sir-rot'ik),
Relating to or affected with cirrhosis or advanced fibrosis.
Farlex Partner Medical Dictionary © Farlex 2012

cir·rhot·ic

(sĭr-rot'ik)
Relating to or affected with cirrhosis or advanced fibrosis.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

cirrhotic

(sĭ-rŏt′ĭk)
Pert. to or affected with cirrhosis.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
Until we have studies that reveal a clear association between beta-blockers and development of hepatorenal syndrome, I will continue to recommend the use of beta-blockers in cirrhotic patients at risk for first variceal hemorrhage.
Routine endoscopic screening of all cirrhotic patients with or without varices carries health service cost implications.
The study concluded that those patients who were cirrhotic at the start of treatment had the highest annual incidence of HCC (1.82%, 95% CI, 1.52-2.12%vs 0.34%, 95% CI, 0.24-0.45% in patients who did not have cirrhosis).
A total of 532 cirrhotic patients were screened during the period from January 2016 to June 2017 for study participation, and 173 were excluded from the study; of these, 149 had did not satisfy the exclusion criteria, and 24 declined to participate.
Thus, AFP level should not be considered as a diagnostic marker; this was in consistent with a previous study.[1] On imaging, D-HCC presented as diffusely distributed nodules in the liver,[2] which resembled cirrhotic nodules.
There is some evidence that [beta]-blockade may help some cirrhotic patients with baseline prolonged QT interval.
The analysis of upper gastrointestinal bleeding in cirrhotic patients and the evaluation of different parameters as possible prognostic factors for mortality in those patients.
Other variables (age, sex, alcohol, smoking, HVPG) in a univariate analysis showed no significant difference between cirrhotic patients with and without PU [39].
According to population studies, portal vein thrombosis (PVT) is observed in approximately 40% of cirrhotic patients.
We retrospectively reviewed the medical record of 100 consecutive patients who were found to be cirrhotic and to have complete video capsule studies between 2010 and 2016 at the University of Massachusetts, UMass Medical Center.
The aim of this study was to compare whether the clinical effect of primary prophylaxis with lactulose or LOLA or rifaximin in cirrhotic patients with AVB is better than placebo for preventing the development of HE.
In the present study, we aimed to determine the correlation between RIPK3 with the degree of neutrophil infiltration in the liver and the related prognosis in the end-stage alcoholic cirrhotic patients.